BIRAC

"As communicated by the manufacturers, the monthly vaccine production capacity of Covishield is projected to be increased from 110…

If approved, it will be the world's first DNA vaccine against coronavirus and the fourth to become available in the country

Animal models that closely resemble the pathogenesis of SARS-CoV-2-induced disease in humans are essential for research on disease…

The CEPI laboratory will be a great addition to the ability of THSTI to enhance the quality of services towards making vaccine and…

It will identify up to 25 best health tech solutions from startups/ SMEs and provide pilot testbeds in collaboration with State…

According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020

It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…

The clinical trials are being conducted by JSS Medical Research as the clinical research partner

Fourteen awards and eleven appreciations under SITARE-GYTI, seven awards and 16 appreciations under SRISTI-GYTI were presented

The partnership will allow Dr Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded…